CORE--PEDIATRIC SICKLE CELL PROGRAM
核心--儿科镰状细胞项目
基本信息
- 批准号:6667543
- 负责人:
- 金额:$ 22.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-04-01 至 2003-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The pediatric clinical core provides comprehensive care for 235 children,
teenagers, and young adults with sickle cell disease (SCD) in 222 families
. The pediatric clinical care component of patient services is a system
of high quality, readily available medical and psychosocial care that
responds to the patient's needs. Our multidisciplinary approach integrates
the skills of medical subspecialists, social workers, counselors,
psychologists, and nurses to meet the patient's and family's needs. The
majority of the patients in this program are born in the Greater
Cincinnati area and are identified by newborn screening. The Cincinnati
Comprehensive Sickle Cell Center (CCSCC) continues to take a leadership
role in insuring appropriate and timely follow-up for infants born in this
area. No baby in the Cincinnati area who was identified by newborn
screening as having a sickle hemoglobinopathy has been lost to follow-up.
The clinical care component works effectively with the primary care
provider to coordinate care with a minimum of redundancy and maximum of
benefits. The clinical care component emphasizes a smooth transition into
adult care and addresses problems of education, vocational, and
psychosocial aspects of this chronic disease. The clinical care component
also serves to promote both clinical and basis research that may benefit
patients with SCD.
The specific aims of the Pediatric Clinical Core are 1) to provide
comprehensive care to patients and families of patients enrolled in the
pediatric clinic; 2) to adapt the traditional concept of comprehensive
care to the present day reality of managed care by which patient enrolled
in various managed health care plans continue to receive the benefits of
a comprehensive program; 3) to provide training opportunities for
residents, fellows, medical students, nursing students genetic counseling
students, as well as other health care professionals; 4) to develop a
transition clinic for adolescent patients as part of a transition program
the goals of which are to help adolescents make a successful transition to
an adult comprehensive care program; and 5) to maintain a stable resource
of patients for the clinical and basic science research activities, and to
provide clinical data for those projects.
儿科临床核心为235名儿童提供全面护理,
222 个家庭中患有镰状细胞病 (SCD) 的青少年和年轻人
。患者服务的儿科临床护理部分是一个系统
高质量、随时可用的医疗和社会心理护理
满足患者的需求。我们的多学科方法整合了
医学专科医生、社会工作者、辅导员的技能,
心理学家和护士来满足患者和家人的需求。这
该计划中的大多数患者出生在大
辛辛那提地区并通过新生儿筛查确定。辛辛那提
综合镰状细胞中心 (CCSCC) 继续保持领先地位
在确保对在此出生的婴儿进行适当和及时的随访方面发挥作用
区域。辛辛那提地区没有婴儿被新生儿识别
因患有镰状血红蛋白病而进行的筛查已失访。
临床护理部分与初级护理有效配合
提供者以最小的冗余和最大的冗余来协调护理
好处。临床护理部分强调平稳过渡到
成人护理并解决教育、职业和
这种慢性疾病的心理社会方面。临床护理部分
也有助于促进可能受益的临床和基础研究
患有 SCD 的患者。
儿科临床核心的具体目标是 1) 提供
为参加该项目的患者和患者家属提供全面护理
儿科诊所; 2)适应传统的综合观念
护理对当今患者登记的管理式护理的现实
在各种管理医疗保健计划中继续获得以下好处
全面的计划; 3)提供培训机会
住院医师、研究员、医学生、护理生遗传咨询
学生以及其他医疗保健专业人员; 4)开发一个
作为过渡计划的一部分,为青少年患者提供过渡诊所
其目标是帮助青少年成功过渡到
成人综合护理计划; 5)维持稳定的资源
患者进行临床和基础科学研究活动,并
为这些项目提供临床数据。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KAREN A KALINYAK其他文献
KAREN A KALINYAK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KAREN A KALINYAK', 18)}}的其他基金
DIPYRIDAMOLE/MAGNESIUM TO IMPROVE SICKLE CELL HYDRATION
双嘧达莫/镁改善镰状细胞水合作用
- 批准号:
7607766 - 财政年份:2007
- 资助金额:
$ 22.86万 - 项目类别:
Dipyridamole/Magnesium to Improve Sickle Cell Hydration
双嘧达莫/镁改善镰状细胞水合作用
- 批准号:
6782210 - 财政年份:2003
- 资助金额:
$ 22.86万 - 项目类别:
MANAGEMENT OF SICKLE CELL VASO-0CCLUSIVE EPISODES
镰状细胞 VASO-0 闭塞性发作的处理
- 批准号:
6584668 - 财政年份:2002
- 资助金额:
$ 22.86万 - 项目类别:
MANAGEMENT OF SICKLE CELL VASO-0CCLUSIVE EPISODES
镰状细胞 VASO-0 闭塞性发作的处理
- 批准号:
6667541 - 财政年份:2002
- 资助金额:
$ 22.86万 - 项目类别:
MANAGEMENT OF SICKLE CELL VASO-0CCLUSIVE EPISODES
镰状细胞 VASO-0 闭塞性发作的治疗
- 批准号:
6456258 - 财政年份:2001
- 资助金额:
$ 22.86万 - 项目类别:
MANAGEMENT OF SICKLE CELL VASO-0CCLUSIVE EPISODES
镰状细胞 VASO-0 闭塞性发作的治疗
- 批准号:
6325980 - 财政年份:2000
- 资助金额:
$ 22.86万 - 项目类别:
相似海外基金
Trajectories of Depression and Alcohol Use in Black and White Adolescent Girls
黑人和白人青春期女孩的抑郁和酗酒轨迹
- 批准号:
7183715 - 财政年份:2006
- 资助金额:
$ 22.86万 - 项目类别:
Risk Factors: Development African American Youth
风险因素:非洲裔美国青年的发展
- 批准号:
7084841 - 财政年份:2006
- 资助金额:
$ 22.86万 - 项目类别:
Integrating Prenatal Care to Reduce HIV/STDs Among Teens: A Translational Study
整合产前护理以减少青少年艾滋病毒/性病:一项转化研究
- 批准号:
7163884 - 财政年份:2006
- 资助金额:
$ 22.86万 - 项目类别:
Validity of DSM-IV ADHD in African Americans
DSM-IV ADHD 在非裔美国人中的有效性
- 批准号:
7221652 - 财政年份:2006
- 资助金额:
$ 22.86万 - 项目类别:
Effects of Parenting/Family Functioning on Adolescent
养育/家庭功能对青少年的影响
- 批准号:
7146534 - 财政年份:2006
- 资助金额:
$ 22.86万 - 项目类别: